Henning Beck-Nielsen

Professor, MD

  • Campusvej 55

    5230 Odense M

    Denmark

1990 …2019
If you made any changes in Pure these will be visible here soon.

Activities 1995 2017

Filter
Talks and presentations in private or public companies

Hvad er de reelle årsager til type 2 diabetes

Henning Beck-Nielsen (Lecturer)
21. Nov 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Efficacy of novel antidiabetic agents

Henning Beck-Nielsen (Lecturer)
17. Nov 201620. Nov 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

How important is lactic acidosis as complication of metformin therapy?

Henning Beck-Nielsen (Lecturer)
12. Sep 201616. Sep 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

Diabetes mellitus: Individualised approach

Henning Beck-Nielsen (Lecturer)
17. Jun 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

SGLT2 Inhibitors and Diabetic Ketoacidosis - “The European Experience"

Henning Beck-Nielsen (Lecturer)
24. Oct 201525. Oct 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

The Type 2 Diabetes Epidemic – Pathophysiology, treatment and prevention

Henning Beck-Nielsen (Lecturer)
21. Oct 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Diabetes mellitus: Individualised approach

Henning Beck-Nielsen (Lecturer)
17. Jun 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Type 2 diabetes er flere sykdommer - konsekvenser for behandling

Henning Beck-Nielsen (Lecturer)
23. Apr 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Future treatment of type 2 diabetes based on pathophysiological phenotypes

Henning Beck-Nielsen (Lecturer)
7. Nov 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Individualized Treatment in Type 2 Diabetes is Cost-effective

Henning Beck-Nielsen (Lecturer)
22. Oct 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Dagens Medicin: Vejen til bedre diabetesbehandling

Henning Beck-Nielsen (Speaker)
3. Oct 2014 → …

Activity: Talks and presentationsTalks and presentations in private or public companies

Metabolic abnormities associated with LADA

Henning Beck-Nielsen (Lecturer)
4. Jun 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Future treatment of type 2 diabetes based on pathophysiological phenotypes

Henning Beck-Nielsen (Lecturer)
17. Jan 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Pathophysiologic phenotypes of patients clinically diagnosed as type 2 diabetes

Henning Beck-Nielsen (Lecturer)
23. Sep 201327. Sep 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

DD2 - A nationwide study for prevention of complications in type 2 diabetes

Henning Beck-Nielsen (Lecturer)
30. May 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Tailored treatment of type 2 diabetes based on present pathophysiology

Henning Beck-Nielsen (Lecturer)
10. May 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Diabetes mellitus: En folkesygdom i hastig udvikling

Henning Beck-Nielsen (Lecturer)
2. May 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Type 2 diabetes: Ætiologi og patogenese

Henning Beck-Nielsen (Lecturer)
26. Feb 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Metabolic abnormalities in skeletal muscle in type 2 diabetes

Henning Beck-Nielsen (Lecturer)
28. Jan 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Molecular defects in glucose disposal in skeletal muscles from subjects with type 2 diabetes

Henning Beck-Nielsen (Lecturer)
7. Jun 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Behandling af type 1 diabetes - hvad bringer fremtiden?

Henning Beck-Nielsen (Lecturer)
3. May 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Diabetes and influence on vessels and nerves

Henning Beck-Nielsen (Lecturer)
26. Apr 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Diabetes mellitus

Henning Beck-Nielsen (Lecturer)
20. Apr 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Type 2 diabetes

Henning Beck-Nielsen (Lecturer)
15. Mar 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Det metaboliske syndrom i daglig klinik

Henning Beck-Nielsen (Lecturer)
3. Nov 2011

Activity: Talks and presentationsTalks and presentations in private or public companies

The 10th Congress of the European Association for Clinical Pharmacology and Therapeutics

Henning Beck-Nielsen (Speaker)
26. Jun 201129. Jun 2011

Activity: Talks and presentationsTalks and presentations in private or public companies

Should presence of cardiovascular disease determine glycaemia target?

Henning Beck-Nielsen (Lecturer)
25. May 2011

Activity: Talks and presentationsTalks and presentations in private or public companies

A hypoglycaemia alarm based on continuous EEG monitoring and real-time data processing

Henning Beck-Nielsen (Lecturer)
2011

Activity: Talks and presentationsTalks and presentations in private or public companies

Endocrine Research Unit

Henning Beck-Nielsen (Lecturer)
26. Nov 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Organisation of Diabetes Carein Denmark

Henning Beck-Nielsen (Lecturer)
11. Nov 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Hypoglykæmi

Henning Beck-Nielsen (Lecturer)
30. Sep 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Translational Science in the Metabolic Syndrome – future directions

Henning Beck-Nielsen (Lecturer)
20. Jul 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

HOPE

Henning Beck-Nielsen (Speaker)
30. Jun 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

The Pathophysiology of Type 2 Diabetesand LADA

Henning Beck-Nielsen (Lecturer)
9. Jun 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Fokus på nye og kommende proteinbaserede diabetes-lægemidler

Henning Beck-Nielsen (Lecturer)
4. May 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

  T2D - Fra epidemiologi til individuel behandling

Henning Beck-Nielsen (Lecturer)
4. May 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Insulin treatment – from August Krogh to the artificial pancreas

Henning Beck-Nielsen (Lecturer)
2010

Activity: Talks and presentationsTalks and presentations in private or public companies

EVALUATION OF CLINICAL RESEARCH IN FINLAND AND SWEDEN

Henning Beck-Nielsen (Lecturer)
20. Nov 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

Henning Beck-Nielsen (Lecturer)
3. Nov 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

Henning Beck-Nielsen (Lecturer)
20. Oct 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  The Pathophysiology of Type 2 Diabetes

Henning Beck-Nielsen (Lecturer)
5. Oct 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

Effect of hyperglycaemia on whole-body glucose metabolism and muscle glycogen synthase activity during physiological hyperinsulinaemia in type 2 diabetes

Henning Beck-Nielsen (Speaker)
30. Sep 20092. Oct 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Nye landvindinger i diabetesbehandlingen

Henning Beck-Nielsen (Lecturer)
24. Sep 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Organisation of Diabetes Carein Denmark

Henning Beck-Nielsen (Lecturer)
24. Sep 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Clinical aspects of type 2 diabetes

Henning Beck-Nielsen (Lecturer)
26. Aug 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

Henning Beck-Nielsen (Lecturer)
6. Jul 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

Henning Beck-Nielsen (Lecturer)
30. Jun 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  The Dysmetabolic Syndrome

Henning Beck-Nielsen (Lecturer)
25. May 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Nye landvindinger i diabetesbehandlingen

Henning Beck-Nielsen (Lecturer)
5. May 2009

Activity: Talks and presentationsTalks and presentations in private or public companies

  Diabetesomsorg - Fra Fyn og tilbage igen

Henning Beck-Nielsen (Lecturer)
6. Mar 2009

Activity: Talks and presentationsTalks and presentations in private or public companies